Active ingredients:

Cefuroxime as sterile cefuroxime sodium - 250 mg, 750 mg or 1.5 g.

CEFUROXIME-BCPP is a 2nd generation cephalosporin antibiotic for intramuscular or intravenous administration. CEFUROXIME-BCPP is a bactericidal agent with a wide-spectrum activity against gram-positive and gram-negative microorganisms.

Indications

CEFUROXIME-BCPP is indicated for the treatment of infections caused by CEFUROXIME-susceptible microorganisms:

• respiratory tract infections (acute and chronic bronchitis, bacterial pneumonia, infected bronchiectasis, lung abscess and postoperative chest infections;
• ear, nose and throat infections sinusitis, tonsillitis, pharyngitis, otitis media);
• urinary tract infections (acute and chronic pyelonephritis, cystitis, asymptomatic bacteriuria);
• soft tissue infections (cellulitis, erysipelas, wound infections);
• bone and joint infections (osteomyelitis, septic arthritis);
• obstetric and gynaecological infections, pelvic inflammatory disease;
• gonorrhoea, particularly if penicillin is unsuitable;
• other infections (septicaemia, meningitis, peritonitis).

Dosage and pharmaceutical form:

powder for solution for injection 250 mg in vial:  No.1 vial per package; 5 vials in cassette, 1 cassette in case.

powder for solution for injection 750 mg in vial:  No.1 vial per package; 5 vials in cassette, 1 cassette in case; 1 vial together with solvent (water for injection) 5 ml or 10 ml in an ampoule in a pack with cardboard partition.

powder for solution for injection 1.5 g in vial:  No.1 vial per package; 5 vials in cassette, 1 cassette in case.